Delisting riskPopularity #4,698
Impact BioMedical (IBO)
Commercializes health-and-wellness patents and Celios air-purification products.
$0.5276
vs last close−0.03 (−5.06%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 3.56% | 303.8K shares | |
|---|---|---|---|
| 19 holders · as of Jun 30, 2026 | |||
| Other | 96.44% | 8.24M shares | |
| remainder | |||
8.54M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (8.54M in the company's Sep 23, 2026 report, 107.82M elsewhere); stakes use the report.
13F, as of Jun 30, 2026
19 holders · 3.83M shares · 2 new positions · 6 increased · 4 reduced · 2 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 1.19M | 13.87% | −7.8K | Aug 12, 2026 |
| Vanguard Capital Management LLC | 808.7K | 9.47% | +100.5K | Aug 13, 2026 |
| State Street Corp | 607.9K | 7.12% | 0 | Aug 7, 2026 |
| Vanguard Fiduciary Trust Co | 589.4K | 6.90% | +4.2K | Aug 13, 2026 |
| BlackRock, Inc. | 259.9K | 3.04% | 0 | Aug 7, 2026 |
| Northern Trust Corp | 235.5K | 2.76% | −8.5K | Aug 13, 2026 |
| Citadel Advisors LLC | 49.6K | 0.58% | +49.6Knew | Sep 2, 2026 |
| Vanguard Global Advisers, LLC | 32.2K | 0.38% | 0 | Aug 13, 2026 |
13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.